The association between TNF-receptors (TNFR1 and TNFR2) and mortality as well as kidney function decline in patients with chronic kidney disease
- PMID: 39697981
- PMCID: PMC11653433
- DOI: 10.48101/ujms.v129.10726
The association between TNF-receptors (TNFR1 and TNFR2) and mortality as well as kidney function decline in patients with chronic kidney disease
Abstract
Background: Higher circulating levels of tumor necrosis factor (TNF) alpha receptors 1 (TNFR1) and 2 (TNFR2) are associated with increased long-term mortality and impaired kidney function.
Aim: To study associations between levels of TNFR1 and TNFR2 and all-cause mortality as well as estimated glomerular filtration rate (eGFR) decline.
Population and methods: Patients with chronic kidney disease (CKD) stages 3-5 in the Salford Kidney Study were included. Associations between one standard deviation increase in plasma TNFR1 and TNFR2 and mortality were estimated by Cox regression models with hazard ratios (HRs) and 95% confidence intervals adjusted for age, sex, eGFR based on creatinine and cystatin C, urine-protein, C-reactive protin, cardiovascular comorbidity, smoking habits, and diabetes. Differences in eGFR decline in relation to plasma TNFR1 and TNFR2 were estimated by both linear and logistic regression models, with regression coefficients and odds ratios (ORs).
Results: Univariate models showed significant associations between TNFR1 (n = 985) and TNFR2 (n = 988) and all-cause mortality based on 7424 person-years at risk, but in the fully adjusted models with continuous variables significant only for TNFR2 HR 1.17 (1.03-1.34), but with a borderline value for TNFR1 HR 1.15 (1.00-1.31). For rapid decliners, that is, eGFR decline in highest TNFR-receptor quartile versus quartiles 1-3, the decline was 1.60% per month (interval 0.78-10.99). For eGFR decline in continuous models, the fully adjusted ORs were for TNFR1 1.29 (0.92-1.81) and for TNFR2 1.33 (0.90-1.98).
Conclusions: TNFR2 was associated with mortality, but TNFR1 was not, although showing a borderline value. Neither TNFR1 nor TNFR2 predicted decline in kidney function. TNFR1 and TNFR2 portray interesting aspects in patients with CKD, but the clinical utility seems limited.
Keywords: Chronic kidney disease; Soluble Tumor Necrosis Factor Receptor (TNFR); cardiovascular diseases; cardiovascular risk factors; decline in kidney function; mortality.
© 2024 The Author(s). Published by Upsala Medical Society.
Conflict of interest statement
Not applicable, the authors of this manuscript have no conflict of interest to disclose.
Similar articles
-
Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.J Am Soc Nephrol. 2012 Mar;23(3):516-24. doi: 10.1681/ASN.2011060628. Epub 2012 Jan 19. J Am Soc Nephrol. 2012. PMID: 22266664 Free PMC article.
-
Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.Am J Kidney Dis. 2022 Jun;79(6):849-857.e1. doi: 10.1053/j.ajkd.2021.09.018. Epub 2021 Nov 6. Am J Kidney Dis. 2022. PMID: 34752914 Free PMC article.
-
Association between graft function and serum TNF-α, TNFR1 and TNFR2 levels in patients with kidney transplantation.Ren Fail. 2015 Jun;37(5):871-6. doi: 10.3109/0886022X.2015.1015425. Epub 2015 Feb 24. Ren Fail. 2015. PMID: 25707514
-
TNFR1 is associated with short-term mortality in patients with diabetes and acute dyspnea seeking care at the emergency department.Acta Diabetol. 2020 Oct;57(10):1145-1150. doi: 10.1007/s00592-020-01527-3. Epub 2020 Apr 12. Acta Diabetol. 2020. PMID: 32281000 Free PMC article.
-
TNFR1 and TNFR2, Which Link NF-κB Activation, Drive Lung Cancer Progression, Cell Dedifferentiation, and Metastasis.Cancers (Basel). 2023 Aug 28;15(17):4299. doi: 10.3390/cancers15174299. Cancers (Basel). 2023. PMID: 37686574 Free PMC article. Review.
References
-
- Carlsson AC, Juhlin CC, Larsson TE, Larsson A, Ingelsson E, Sundstrom J, et al. . Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes – findings from two community based cohorts of elderly. Atherosclerosis. 2014;237(1):236–42. doi: 10.1016/j.atherosclerosis.2014.09.005 - DOI - PubMed
-
- Carlsson AC, Ostgren CJ, Nystrom FH, Lanne T, Jennersjo P, Larsson A, et al. . Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes. Cardiovasc Diabetol. 2016;15:40. doi: 10.1186/s12933-016-0359-8 - DOI - PMC - PubMed
-
- Carlsson AC, Nordquist L, Larsson TE, Carrero JJ, Larsson A, Lind L, et al. . Soluble tumor necrosis factor receptor 1 is associated with glomerular filtration rate progression and incidence of chronic kidney disease in two community-based cohorts of elderly individuals. Cardiorenal Med. 2015;5(4):278–88. doi: 10.1159/000435863 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous